PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
Atherosclerosis is a primary precursor of cardiovascular disease (CVD), the leading cause of death worldwide. While proprotein convertase subtilisin/kexin 9 (PCSK9) contributes to CVD by degrading low-density lipoprotein receptors (LDLR) and altering lipid metabolism, PCSK9 also influences vascular...
Main Authors: | Jounghyun H. Lee, Kevin L. Shores, Jason J. Breithaupt, Caleb S. Lee, Daniella M. Fodera, Jennifer B. Kwon, Adarsh R. Ettyreddy, Kristin M. Myers, Benny J. Evison, Alexandra K. Suchowerska, Charles A. Gersbach, Kam W. Leong, George A. Truskey |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2023-12-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/5.0167440 |
Similar Items
-
Modeling statin myopathy in a human skeletal muscle microphysiological system.
by: Anandita Ananthakumar, et al.
Published: (2020-01-01) -
Microphysiological systems
by: James J. Hickman, et al.
Published: (2019-12-01) -
Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing
by: Leslie Donoghue, et al.
Published: (2021-01-01) -
Light-triggered cardiac microphysiological model
by: V. Vurro, et al.
Published: (2023-06-01) -
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
by: Emily Punch, et al.
Published: (2022-02-01)